Annual report pursuant to Section 13 and 15(d)

Statements of Stockholders' Equity (Deficit)

v3.6.0.2
Statements of Stockholders' Equity (Deficit) - USD ($)
Total
Preferred Convertible Stock
Common Stock
Additional Paid-in Capital
Note to Employee
Accumulated Deficit
Beginning balance at Dec. 31, 2013 $ (39,505,672) $ 5,968,549 $ 1,016,783     $ (46,491,004)
Beginning balance, shares at Dec. 31, 2013   6,244,174 380,566      
Stock-based compensation 657,730     $ 657,730    
Shares issued pursuant to stock awards, shares     244,616      
Exercise of stock options $ 220   $ 220      
Exercise of stock options, shares 100   100      
Change in note to employee $ (266,282)       $ (266,282)  
Effect of accretion to redemption value (2,144,434)     (657,730)   (1,486,704)
Net income (loss) 3,588,300         3,588,300
Ending balance at Dec. 31, 2014 (37,670,138) $ 5,968,549 $ 1,017,003   (266,282) (44,389,408)
Ending balance, shares at Dec. 31, 2014   6,244,174 625,282      
Stock-based compensation 341,554     341,554    
Shares issued pursuant to stock awards, shares     16,300      
Exercise of stock options $ 77,372   $ 77,372      
Exercise of stock options, shares 24,260   24,260      
Change in note to employee $ 266,282       $ 266,282  
Effect of accretion to redemption value (2,157,550)     (341,554)   (1,815,996)
Net income (loss) (270,342)         (270,342)
Ending balance at Dec. 31, 2015 (39,412,822) $ 5,968,549 $ 1,094,375     (46,475,746)
Ending balance, shares at Dec. 31, 2015   6,244,174 665,842      
Stock-based compensation 298,535     298,535    
Conversion of warrants 249,215     249,215    
Conversion of warrants, shares     127,143      
Exercise of stock options $ 137,403   $ 112,101 25,302    
Exercise of stock options, shares 58,155   58,155      
Effect of accretion to redemption value $ (1,356,707)     (547,750)   (808,957)
Change in par value from no par value to $0.0001     $ (1,206,391) 1,206,391    
Issuance of common stock upon initial public offering, net of issuance costs 10,816,978   $ 170 10,816,808    
Issuance of common stock upon initial public offering, net of issuance costs, shares     1,700,100      
Issuance of warrants to underwriters 126,218     126,218    
Conversion of preferred redeemable convertible stock to common stock upon initial public offering 44,463,613   $ 378 44,463,235    
Conversion of preferred redeemable convertible stock to common stock upon initial public offering, shares     3,778,753      
Conversion of preferred convertible stock to common stock upon initial public offering   $ (5,968,549) $ 126 5,968,423    
Conversion of preferred convertible stock to common stock upon initial public offering, shares   (6,244,174) 1,259,187      
Issuance of common stock upon secondary public offering, net of issuance costs 25,976,262   $ 169 25,976,093    
Issuance of common stock upon secondary public offering, net of issuance costs, shares     1,685,882      
Net income (loss) 3,733,707         3,733,707
Ending balance at Dec. 31, 2016 $ 45,032,402   $ 928 $ 88,582,470   $ (43,550,996)
Ending balance, shares at Dec. 31, 2016     9,275,062